Solomon Demetrius, Moon Jukrin, Parmasad Vishala, Hernandez Sara, Wiegmann Douglas, Safdar Nasia
Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA.
Department of Industrial and Systems Engineering, University of Iowa, Iowa City, IA, USA.
Appl Ergon. 2025 May;125:104419. doi: 10.1016/j.apergo.2024.104419. Epub 2024 Dec 4.
Clostridioides difficile infection is the most common healthcare-associated infection, causing almost half a million infections in the United States annually. Inappropriate antibiotic usage is a known risk factor. Antibiotic stewardship efforts aim to optimize prescribing. Evidence supports pre-prescription authorization as a highly effective intervention. A pre-prescription intervention for fluoroquinolone antibiotics via a computerized clinical decision support tool called a "best practice alert" (BPA) embedded in the patient's electronic health records has high potential for improving antibiotic stewardship. However, information is scant about the factors that might impact the uptake and effectiveness of this BPA and other similar evidence-based interventions when spread and adopted across multiple independent sites. Therefore, we utilized the Consolidated Framework for Implementation Research (CFIR) to understand the facilitators and barriers to the implementation process that influence clinical and implementation outcomes. In doing so, we conducted semi-structured interviews with 18 healthcare professionals across four hospitals. Our research team performed a qualitative analysis to understand the contextual factors influencing the implementation outcomes, such as acceptability and sustainability.
The following themes highlight the factors affecting the implementation of this healthcare innovation.
Designing interventions that are customizable and low maintenance.
Maturity level of the Antibiotic Stewardship Program.
Implementer's experience/attitudes in implementing healthcare innovations.
The ability to prioritize initiatives as the organization responds to unintended circumstances (e.g., COVID).
Adapting implementation approaches and strategies as technology spreads.
艰难梭菌感染是最常见的医疗保健相关感染,在美国每年导致近50万例感染。不适当使用抗生素是已知的风险因素。抗生素管理措施旨在优化处方。有证据支持处方前授权是一种高效干预措施。通过嵌入患者电子健康记录中的名为“最佳实践警报”(BPA)的计算机化临床决策支持工具对氟喹诺酮类抗生素进行处方前干预,在改善抗生素管理方面具有很大潜力。然而,关于在多个独立地点推广和采用时可能影响这种BPA及其他类似循证干预措施的采用率和有效性的因素,相关信息却很少。因此,我们利用实施研究综合框架(CFIR)来了解影响临床和实施结果的实施过程中的促进因素和障碍。在此过程中,我们对四家医院的18名医疗保健专业人员进行了半结构化访谈。我们的研究团队进行了定性分析,以了解影响实施结果的背景因素,如可接受性和可持续性。
以下主题突出了影响这一医疗创新实施的因素。
设计可定制且维护成本低的干预措施。
抗生素管理计划的成熟程度。
实施者在实施医疗创新方面的经验/态度。
组织应对意外情况(如新冠疫情)时对各项举措进行优先排序的能力。
随着技术传播调整实施方法和策略。